Skip to main content
. 2010 Feb;17(1):17–24. doi: 10.3747/co.v17i1.436

TABLE V.

Cost–utility analysis

Costs (2006 CA$) dfys lys qalys
Regimen
folfox 27,726 9.861 10.418 8.048
 5fu/lv 12,317 8.781 9.765 7.409
Incremental 15,409 1.080 0.653 0.639
icera 14,266 23,598 24,104

dfy = disease-free years; ly = life-years; qaly = quality-adjusted life-years; folfox = folinic acid, 5-fluorouracil, oxaliplatin; 5fu = 5-fluorouracil; lv = leucovorin; icer = incremental costeffectiveness ratio.